Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
35.00 HKD | -2.51% |
|
+5.90% | -4.37% |
Feb. 06 | Innovent Biologics Logs 25% Boost in Q4 2024 Product Revenue | MT |
Feb. 06 | Innovent Biologics, Inc. Reports Revenue Results for the Fourth Quarter and Full Year of 2024 | CI |
Capitalization | 55.15B 58.81B 7.55B 7.3B 6.89B 6.08B 10.8B 655B 11.99B 81.99B 30.43B 272B 28.28B 27.73B 1,149B | P/E ratio 2024 * |
-73.5x | P/E ratio 2025 * | 269x |
---|---|---|---|---|---|
Enterprise value | 50.17B 53.49B 6.87B 6.64B 6.26B 5.53B 9.82B 596B 10.9B 74.58B 27.67B 248B 25.73B 25.22B 1,045B | EV / Sales 2024 * |
6.1x | EV / Sales 2025 * | 4.68x |
Free-Float |
93.21% | Yield 2024 * |
-
| Yield 2025 * | - |
Last Transcript: Innovent Biologics, Inc.
1 day | -1.24% | ||
1 week | +9.62% | ||
Current month | +8.62% | ||
1 month | +7.00% | ||
3 months | -7.59% | ||
6 months | -13.81% | ||
Current year | -1.91% |







Director | Title | Age | Since |
---|---|---|---|
De Chao Yu
CEO | Chief Executive Officer | 62 | 2011-04-27 |
Fei You
DFI | Director of Finance/CFO | 46 | 2024-02-04 |
Ghang Shou Gao
CTO | Chief Tech/Sci/R&D Officer | - | 2020-10-31 |
Manager | Title | Age | Since |
---|---|---|---|
De Chao Yu
CHM | Chairman | 62 | 2011-04-27 |
Charles Cooney
BRD | Director/Board Member | 81 | 2015-10-17 |
Hao Xi Ede
BRD | Director/Board Member | 66 | 2018-06-03 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.78% | 0 M€ | -20.08% | - | |
1.77% | 0 M€ | -27.92% | - | |
1.09% | 0 M€ | -9.86% | - | |
0.68% | 0 M€ | -14.14% | - |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
-1.24% | +9.62% | -0.28% | +5.12% | 7.64B | ||
-0.29% | -6.21% | -11.61% | +3.24% | 82.2B | ||
+3.89% | +17.40% | +44.05% | +51.29% | 55.45B | ||
-0.94% | +1.94% | +102.18% | +116.90% | 37.4B | ||
-2.21% | -2.07% | -42.16% | -36.65% | 20.77B | ||
-3.57% | +7.23% | +392.19% | +798.22% | 14.4B | ||
+0.35% | +0.29% | +75.29% | +146.87% | 13.51B | ||
-2.88% | -10.05% | +15.04% | -0.85% | 13.16B | ||
+0.08% | +1.78% | -28.16% | -30.63% | 12.1B | ||
-1.84% | -2.83% | +5.42% | -42.95% | 11.67B | ||
Average | -0.85% | +1.91% | +55.20% | +101.06% | 26.83B | |
Weighted average by Cap. | +0.03% | +1.81% | +41.07% | +72.15% |
2024 * | 2025 * | |
---|---|---|
Net sales | 8.23B 8.77B 1.13B 1.09B 1.03B 906M 1.61B 97.68B 1.79B 12.23B 4.54B 40.58B 4.22B 4.14B 171B | 10.85B 11.57B 1.48B 1.43B 1.35B 1.2B 2.12B 129B 2.36B 16.13B 5.98B 53.52B 5.56B 5.45B 226B |
Net income | -766M -817M -105M -101M -95.67M -84.41M -150M -9.1B -167M -1.14B -423M -3.78B -393M -385M -15.97B | 161M 171M 21.98M 21.24M 20.06M 17.69M 31.45M 1.91B 34.91M 239M 88.61M 792M 82.37M 80.74M 3.35B |
Net Debt | -4.99B -5.32B -683M -660M -623M -550M -977M -59.23B -1.08B -7.42B -2.75B -24.61B -2.56B -2.51B -104B | -4.43B -4.72B -606M -585M -553M -488M -866M -52.55B -962M -6.58B -2.44B -21.83B -2.27B -2.22B -92.22B |
Date | Price | Change | Volume |
---|---|---|---|
25-02-11 | 35.00 $ | -2.51% | 2,775,609 |
25-02-11 | 35.90 $ | -1.24% | 7,660,163 |
25-02-10 | 36.35 $ | +0.28% | 9,516,738 |
25-02-07 | 36.25 $ | +1.26% | 11,951,930 |
25-02-06 | 35.80 $ | +8.32% | 15,947,050 |
Delayed Quote Hong Kong S.E., February 11, 2025 at 03:08 am EST
More quotes
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 1801 Stock